Clolar and cardiomegaly Patient Reports February 13, 2012

Clolar Side Effects Report #6086994-X
Clolar side effect was reported by a Physician from UNITED STATES on Feb 11, 2009. Female patient, 73 years of age, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: bronchial wall thickening, bronchitis , cardiomegaly, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, hyponatraemia, nausea . Clolar dosage: 19 MG, QDX5, INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #6099444-4
Clolar side effect was reported by a Physician from UNITED STATES on Feb 18, 2009. Female patient, 73 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: blood sodium decreased, bronchial wall thickening, bronchitis , cardiomegaly, dehydration, haematocrit decreased, haemoglobin decreased, nausea , neutropenia. Clolar dosage: 19 MG, QDX5, INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO, PRILOSEC. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #6110635-6
Clolar side effect was reported by a Physician from UNITED STATES on Feb 26, 2009. Female patient, 73 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: bronchitis , cardiomegaly, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, nausea , neutropenic infection, pneumonia . Clolar dosage: 19 MG, QDX5, INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5610376-5
Clolar side effect was reported by a Physician from UNITED STATES on Jan 17, 2008. Female patient, 69 years of age, weighting 182.1 lb, was diagnosed with bone marrow conditioning regimen and was treated with Clolar. After drug was administered, patient experienced the following side effects: agitation, cardiac failure congestive, cardiomegaly, cerebral ischaemia, condition aggravated, dyspnoea, hallucinations, mixed, hypovolaemia. Clolar dosage: 76 MG, INTRAVENOUS. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient recovered.


Clolar Side Effects Report #5621914-0
Clolar side effect was reported by a Physician from UNITED STATES on Jan 29, 2008. Female patient, 69 years of age, weighting 182.1 lb, was diagnosed with bone marrow conditioning regimen and was treated with Clolar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiomegaly, cerebral ischaemia, metabolic encephalopathy, pneumocystis jiroveci pneumonia. Clolar dosage: 76 MG, INTRAVENOUS. During the same period patient was treated with CAMPATH, MELPHALAN, DILANTIN. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5728165-X
Clolar side effect was reported by a Physician from UNITED STATES on Apr 24, 2008. Female patient, 69 years of age, weighting 146.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with Clolar. After drug was administered, patient experienced the following side effects: agitation, blood creatinine increased, blood potassium decreased, carbon dioxide decreased, cardiac failure congestive, cardiomegaly, diarrhoea, disorientation. Clolar dosage: 76 MG, QD, INTRAVENOUS. During the same period patient was treated with CAMPATH, DILANTIN KAPSEAL, MELPHALAN. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5741054-X
Clolar side effect was reported by a Physician from UNITED STATES on May 07, 2008. Female patient, 69 years of age, weighting 146.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with Clolar. After drug was administered, patient experienced the following side effects: agitation, blood creatinine increased, blood potassium decreased, cardiac failure congestive, cardiomegaly, diarrhoea, hallucination, auditory, hallucination, visual. Clolar dosage: 76 MG,QD; INTRAVENOUS. During the same period patient was treated with CAMPATH, MELPHALAN, DILANTIN KAPSEAL. Patient was hospitalized. Patient died on 05/06/2008.

Clolar Side Effects Report #5756605-9
Clolar side effect was reported by a Physician from UNITED STATES on May 20, 2008. Female patient, 69 years of age, weighting 146.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with Clolar. After drug was administered, patient experienced the following side effects: agitation, cardiac failure congestive, cardiomegaly, cerebral ischaemia, diarrhoea, disorientation, dyspnoea. Clolar dosage: 76 MG, QD, INTRAVENOUS. During the same period patient was treated with CAMPATH, MELPHALAN, DILANTIN KAPSEAL, METOPROLOL TARTRATE, HYDROCHLOROTHIAZIDE, FERROUS SULPHATE, ALLOPURINOL, POTASSIUM CHLORIDE. Patient was hospitalized. Patient died on 05/06/2008.

Clolar Side Effects Report #4998214-5
Clolar side effect was reported by a Health Professional from UNITED STATES on Apr 28, 2006. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , base excess increased, blood bicarbonate increased, breath sounds abnormal, carbon dioxide increased, cardiomegaly, cardiomyopathy , condition aggravated, crepitations. Clolar dosage: 22.5 MG/M2 IV. During the same period patient was treated with CYTOSINE ARABINOSIDE. Patient died on 04/27/2006.


Clolar Side Effects Report #5018834-1
Clolar side effect was reported by a Physician from UNITED STATES on May 17, 2006. Female patient, 71 years of age, weighting 213.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: ascites, atrial fibrillation , blood bicarbonate increased, cardiac disorder, cardiomegaly, dilatation ventricular, electrocardiogram abnormal, electrocardiogram t wave abnormal, embolism. Clolar dosage: 22.5 MG/M2 IV. During the same period patient was treated with CYTOSINE ARABINOSIDE. Patient died on 04/27/2006.